What is Fusion Diagnostics?
Fusion Diagnostics operates as a comprehensive clinical laboratory based in Cedar Knolls, NJ. The company provides an extensive suite of diagnostic testing services, encompassing serology, cytology, virology, and toxicology, among others, with a substantial 99% of tests conducted in-house. Catering to healthcare providers, hospitals, and research facilities, Fusion Diagnostics emphasizes patient-centric care through discounted rates for uninsured individuals and broad acceptance of insurance plans. Their commitment extends to advancing medical diagnostic technology, ensuring the delivery of timely and accurate results.
How much funding has Fusion Diagnostics raised?
Fusion Diagnostics has raised a total of $440K across 2 funding rounds:
Debt
$150K
Debt
$290K
Debt (2020): $150K with participation from PPP
Debt (2021): $290K led by PPP
Key Investors in Fusion Diagnostics
PPP
Public-Private Partnership
PPP
Public-Private Partnership
What's next for Fusion Diagnostics?
The substantial large-scale late-stage funding indicates Fusion Diagnostics is poised for significant scaling and potentially further technological integration or market penetration. This strategic capital infusion will likely fuel advancements in their diagnostic capabilities, expand their service offerings, and reinforce their market presence. The company's focus on operational efficiency and patient accessibility, combined with this recent investment, positions it for sustained growth and leadership in the clinical diagnostics industry.
See full Fusion Diagnostics company page
